Comparison of the Radiological Pattern Between the Cerebral Stroke of Arterial and Venous Origin (PATTERN)
July 27, 2018 updated by: Centre Hospitalier Universitaire, Amiens
There are few published data on the patterns of parenchymal imaging abnormalities in a context of cerebral venous thrombosis (CVT).
The objectives of the present study were to describe the patterns of parenchymal lesions associated with CVT and to determine the lesion sites.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
98
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Amiens, France, 80054
- Chu Amiens
-
Rouen, France, 76000
- CHU Rouen
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
The investigators want to include consecutively hospitalized patients with CVT and parenchymal lesions on magnetic resonance imaging.
Description
Inclusion Criteria:
- hospitalized patients with CVT
- parenchymal lesions on magnetic resonance imaging
Exclusion Criteria:
- No CVT
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
hemorrhagic ischemia
comparison between clinical characteristics and the confirmed diagnosis by RMI (magnetic resonance Imaging)
|
comparison between clinical and radiological characteristics
|
|
nonhemorrhagic ischemia
comparison between clinical characteristics and the confirmed diagnosis by RMI (magnetic resonance Imaging)
|
comparison between clinical and radiological characteristics
|
|
intracerebral hematoma
comparison between clinical characteristics and the confirmed diagnosis by RMI (magnetic resonance Imaging)
|
comparison between clinical and radiological characteristics
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
|---|---|
|
patterns
|
describe the patterns of parenchymal lesions associated with CVT and to determine the lesion sites.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Audrey Arnoux, MD, Chu Amiens
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2017
Primary Completion (Actual)
July 1, 2017
Study Completion (Actual)
July 1, 2017
Study Registration Dates
First Submitted
July 27, 2018
First Submitted That Met QC Criteria
July 27, 2018
First Posted (Actual)
August 2, 2018
Study Record Updates
Last Update Posted (Actual)
August 2, 2018
Last Update Submitted That Met QC Criteria
July 27, 2018
Last Verified
July 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Cardiovascular Diseases
- Vascular Diseases
- Cerebrovascular Disorders
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Embolism and Thrombosis
- Intracranial Thrombosis
- Intracranial Embolism and Thrombosis
- Thromboembolism
- Stroke
- Thrombosis
- Venous Thrombosis
- Sinus Thrombosis, Intracranial
- Sagittal Sinus Thrombosis
Other Study ID Numbers
- PI2017_843_0035
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.